1 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allergy Delabeling in Antibiotic Stewardship - Intervention RENEW-IN Algorithm for assessment of a beta-lactam intervention, EMR Review - Beta Lactam Allergy, Hematologic Malignancy | Phase 4 | Recruiting | Abramson Cancer Center at Penn Medicine | 3800 | 2026-04-20 | 2026-06-17 |
| Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm Individualization of first voriconazole maintenance doses - Aspergillosis Invasive, Fungal Infection | Phase 4 | Not yet recruiting | University Hospital, Grenoble | 30 | 2024-10-01 | 2024-09-03 |
| Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation Ceftolozane / Tazobactam Injection - Pneumonia, Hematologic Malignancy | Phase 4 | Terminated | Weill Medical College of Cornell University | 17 | 2023-01-10 | 2026-01-21 |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults Biological samples - Kidney Transplant, Myeloma | Phase 4 | Completed | Centre Hospitalier Régional d'Orléans | 196 | 2021-03-26 | 2025-12-23 |
Hematologic Neoplasms (4) · Acquired Immunodeficiency Syndrome (1) · Bacteremia (1) · Diabetes Mellitus, Type 2 (1) · Gram-Negative Bacterial Infections (1) · Hypergammaglobulinemia (1) · Multiple Sclerosis (1) · Mycoses (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Pneumonia (1) · Pseudomonas Infections (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms by Site (4) · Infections (3) · Neoplasms (3) · Bacterial Infections and Mycoses (2) · Pathological Conditions, Signs and Symptoms (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bacterial Infections (1) · Blood Protein Disorders (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1)
ceftolozane, tazobactam drug combination (1)
Abramson Cancer Center at Penn Medicine (1) · Centre Hospitalier Régional d'Orléans (1) · University Hospital, Grenoble (1) · Weill Medical College of Cornell University (1)
France (2) · United States (2)
Gautier-Veyret Elodie (1) · Markus Plate, MD (1)